Xiaoyuan Gong Selected Research

Xiaoyuan Gong Research Topics

Disease

7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 10/2014
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2014
5	Leukemia 09/2021 - 10/2018
4	Philadelphia Chromosome 01/2021 - 03/2019
2	Acute Promyelocytic Leukemia 12/2022 - 12/2021
2	Osteoarthritis 04/2022 - 02/2021
2	Inflammation (Inflammations) 02/2021 - 01/2020
2	Hypertrophy 12/2020 - 01/2019
2	Cytokine Release Syndrome 10/2020 - 05/2020
2	Infections 09/2019 - 01/2017
1	Genomic Instability 12/2021
1	Pathologic Constriction (Stenosis) 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Brain Diseases (Brain Disorder) 05/2020
1	Skin Neoplasms (Skin Cancer) 05/2020
1	Lymphoma (Lymphomas) 05/2020
1	Candidemia 01/2020
1	Metaplasia 01/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Neutropenia 01/2017
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2016
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2016
1	Newborn Respiratory Distress Syndrome 01/2016
1	Birth Weight (Birth Weights) 01/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 12/2014

Drug/Important Bio-Agent (IBA)

4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 01/2014
3	Chimeric Antigen ReceptorsIBA 10/2020 - 01/2020
2	venetoclaxIBA 01/2022 - 09/2021
2	CytokinesIBA 02/2021 - 10/2020
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2022
1	Arsenic Trioxide (Trisenox)FDA Link 12/2022
1	TropoelastinIBA 04/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Azacitidine (5 Azacytidine)FDA Link 09/2021
1	alanyl-leucyl-alanyl-leucine (ALAL)IBA 09/2021
1	Peptides (Polypeptides)IBA 02/2021
1	NanogelsIBA 02/2021
1	fucoidanIBA 02/2021
1	glycol-chitosanIBA 02/2021
1	GlycosaminoglycansIBA 02/2021
1	AlloysIBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 01/2021
1	asiatic acidIBA 12/2020
1	Alkaline PhosphataseIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 12/2020
1	Transcription Factors (Transcription Factor)IBA 12/2020
1	Collagen Type I (Type I Collagen)IBA 12/2020
1	Collagen Type II (Type II Collagen)IBA 12/2020
1	Collagen Type XIBA 12/2020
1	Matrix Metalloproteinase 13IBA 12/2020
1	Aggrecans (Aggrecan)IBA 12/2020
1	SteroidsIBA 10/2020
1	ruxolitinibIBA 10/2020
1	Janus KinasesIBA 10/2020
1	spasmolytic polypeptideIBA 01/2020
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 01/2020
1	Bile Acids and Salts (Bile Acids)IBA 01/2020
1	Antifungal AgentsIBA 01/2020
1	HydrogelsIBA 09/2019
1	nilotinib FDA Link 03/2019
1	VinculinIBA 01/2019
1	Actins (F Actin)IBA 01/2019
1	ZyxinIBA 01/2019
1	Core Binding Factors (Core-Binding Factor)IBA 10/2018
1	CBFbeta-MYH11 fusion proteinIBA 10/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2018
1	Co-Repressor ProteinsIBA 04/2018
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2017
1	Arginine (L-Arginine)FDA Link 01/2016
1	Sildenafil Citrate (Viagra)FDA Link 01/2016

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 09/2021 - 10/2014
5	Therapeutics 01/2021 - 01/2020
2	Intra-Articular Injections 04/2022 - 02/2021
1	Stents 01/2021
1	Cell- and Tissue-Based Therapy (Cell Therapy) 05/2020
1	Ligation 04/2018
1	Induction Chemotherapy 01/2017
1	Consolidation Chemotherapy 01/2017
1	Hematopoietic Stem Cell Transplantation 12/2014